Drugs Approved by the FDA

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Bristol-Myers Squibb
Approval Status: Approved March 1998
Treatment for: sickle-cell anemia

General Information

Droxia has been approved for people who have had three or more painful episodes with sickle-cell, which causes red blood cells to become oddly shaped and clump together. While taking the drug, patients must have a blood test every two weeks to ensure that their blood count is not depressed to a level at which they might be at risk for infection or bleeding.